Original language | English |
---|---|
Number of pages | 7 |
Journal | Post Reproductive Health |
DOIs | |
Publication status | Accepted/In press - 17 Jan 2021 |
Externally published | Yes |
BMS, IMS, EMAS, RCOG and AMS joint statement on menopausal hormone therapy and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020
Haitham Hamoda, Susan R. Davis, Antonio Cano, Edward Morris, Sonia Davison, Nicholas Panay, Mary A. Lumsden, Tim Hillard, Tommaso Simoncini
Research output: Contribution to journal › Letter › Other › peer-review